Trials / Completed
CompletedNCT01089868
Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
Quantification of Therapy Effects After Microsurgery, Percutaneous Irradiation and Chemotherapy by FET-PET Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to establish FET-PET as an additional therapy assessment parameter in patients diagnosed with a glioblastoma multiforme receiving radiochemotherapy and adjuvant chemotherapy after previous resection or biopsy.
Conditions
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2011-06-01
- Completion
- 2012-07-01
- First posted
- 2010-03-19
- Last updated
- 2012-08-07
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01089868. Inclusion in this directory is not an endorsement.